-
Founded in:
2002-01-18 -
Country:
China -
Address:
Gucheng Road, Huyi District, Xi'an -
Tax NO.:
91610125221080753H -
Registered Funds:
55.4216 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ofloxacin |
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.
More
This product has a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often has antibacterial activity against multi-drug resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing Haemophilus influenzae and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death. |
82419-36-1 | 30 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Pentoxifylline |
It improves blood rheology by reducing blood viscosity, reduces blood viscosity in a dose-dependent manner, improves red blood cell deformability, improves the blood rheological properties of white blood cells, and inhibits the adhesion and activation of neutrophils. For patients with chronic peripheral arterial vascular disease, it can increase blood flow, affect microcirculation, and improve tissue oxygen supply.
More
It improves blood rheology by reducing blood viscosity, reduces blood viscosity in a dose-dependent manner, improves red blood cell deformability, improves the blood rheological properties of white blood cells, and inhibits the adhesion and activation of neutrophils. For patients with chronic peripheral arterial vascular disease, it can increase blood flow, affect microcirculation, and improve tissue oxygen supply. |
6493-05-6 | 41 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| LEVOFLOXACIN LACTATE |
This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, and gonococci; it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc.
More
This product is the levorotatory form of ofloxacin, and its antibacterial activity is about 2 times that of ofloxacin. Its main mechanism of action is to inhibit bacterial DNA gyrase activity and inhibit bacterial DNA replication. It has the characteristics of broad antibacterial spectrum and strong antibacterial effect. It has strong antibacterial activity against most Enterobacteriaceae, such as Klebsiella pneumoniae, Proteus, Salmonella typhi, Shigella, influenza bacillus, some Escherichia coli, Pseudomonas aeruginosa, and gonococci; it also has good antibacterial effect against some Staphylococci, Streptococcus pneumoniae, Chlamydia, etc. |
294662-18-3 | 11 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium acetate |
Infusion or oral administration of too much or too fast can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure.
More
Infusion or oral administration of too much or too fast can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure. |
12.24g | 127-09-3 | 34 |
| Sodium chloride |
Infusion or oral administration of too much or too fast can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure.
More
Infusion or oral administration of too much or too fast can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure. |
11.7g | 7647-14-5 | 43 |
| Potassium chloride |
Infusion or oral administration of too much or too fast can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure.
More
Infusion or oral administration of too much or too fast can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure. |
0.600g | 7447-40-7 | 39 |
| Calcium chloride |
Infusion or oral administration of too much or too fast can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure.
More
Infusion or oral administration of too much or too fast can cause water and sodium retention, resulting in edema, increased blood pressure, increased heart rate, chest tightness, dyspnea, and even acute left heart failure. |
0.666g | 10043-52-4 | 27 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sodium acetate |
Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.
More
Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure. |
12.24g | 127-09-3 | 34 |
| Sodium chloride |
Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.
More
Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure. |
11.7g | 7647-14-5 | 43 |
| Potassium chloride |
Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.
More
Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure. |
0.600g | 7447-40-7 | 39 |
| Calcium chloride |
Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure.
More
Excessive or rapid infusion or oral administration can cause water and sodium retention, leading to edema, increased blood pressure, increased heart rate, chest tightness, difficulty breathing, and even acute left heart failure. |
0.666g | 10043-52-4 | 27 |